NeoGenomics News and Activities

NeoGenomics is a company listed under the stock ticker NEO (US).

View the org chart displaying its 22 main executives

Most searched biographies at NeoGenomics

• Tony Zook, Chief Executive Officer and Director
• Neil Gunn, Independent Director and Chair of the Innovation, Techn...
• Lynn Tetrault, Non-Executive Chairman of the Board

Popular executive movements at NeoGenomics

• Kristi McKeown has joined the company as Chief Commercial Officer  (posted on May 25 2026).
• Beth Eastland, Executive Vice President of Enterprise Sales, has left the company  (posted on May 25 2026).
• Jeffrey Sherman who is Chief Financial Officer, will become Executive Vice President on Mar. 2, 2026  (posted on January 14 2026).

Click here to view some more movements at NeoGenomics

Create your alert
to follow the executive moves at NeoGenomics.

NeoGenomics has 3,493 competitors including UnitedHealth Group (United States (USA)), Kaiser Permanente (United States (USA)) and HCA (United States (USA)).

Popular M&A news in Healthcare

• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Freeman Health System has acquired Northwest Health (posted on June 2 2026).
• Garner Health has just announced a $100 Million fundraising (posted on May 29 2026).

Popular contacts in Healthcare

• Ari Bousbib - Chairman and Chief Executive Officer at IQVIA
• Gregory Adams - Chief Executive Officer and Chairman of the Board at Kaiser Permanente
• Pablo Legorreta - Chairman of the Board, Founder and Chief Executive Officer at Royalty Pharma

Learn more about the Healthcare industry

Press releases by NeoGenomics

• Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients
• NeoGenomics Announces Chief Executive Officer Succession
• NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan
• NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
• NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma
• NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting
• NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
• Press Release | NeoGenomics Laboratories
• Felicia Williams Joins NeoGenomics Board of Directors
• NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference
• View more press releases Close

Social media about NeoGenomics

• NeoGenomics on Wikipedia, Google News & Yahoo Finance
• NeoGenomics on LinkedIn, X (Twitter) & YouTube